Keynote Lectures (KL)

Figures & data

KL-1 Oxygen: The Poison is in the Dose

KL2 Understanding Causality in HBOC Clinical Trials: The role of Clinical Contextualization

KL-3 Postinjury Resuscitation with Human Polymerized Hemoglobin: The USA Multicenter Trial

Table

	PolyHeme (survivors/N)	Control (survivors/N)	p-value
Day 1	Protocol Compliant
259/279 (92.8 %)	289/311 (92.9%)	1.00
Protocol Violators	57/71 (80.3%)	48/53 (90.6%)	0.14
All Patients	316/350 (90.3%)	337/364 (92.6%)	0.29
Day 30
Protocol Compliant	248/279 (88.9%)	282/311 (90.7%)	0.50
Protocol Violators	55/71 (77.5%)	47/53 (88.7%)	0.15
All Patients	303/350 (86.6%)	329/364 (90.4%)	0.13

KL-4 Introduction of Development on Transfusion Medicine in China

KL-5 Process Engineering of Protein-Based Oxygen Carriers

KL-6 Recovery of Microvascular Perfusion & Oxygen Carrying Capacity: Priorities, Alternatives and Goals in Designing And Using Blood Substitutes

KL-7 Breathing nitric oxide or intravenous administration of nitrite prevents systemic vasoconstriction caused by challenge with murine tetrameric hemoglobin or HBOC-201 in awake mice and lambs

KL-8 Functional and Physiological Characterization of Glutaraldehyde-Polymerized Porcine Hemoglobin

KL-9 Physicochemical Characteristics and Physiological Performances of Artificial Oxygen Carriers (Hb-Vesicles And Albumin-Hemes)

KL-10 Free Oxygen Flow a New Paradigm

HL-11 Clinical Application of Cellular Type Artificial Oxygen Carrier-Hemoglobin Vesicle (Hbv)

KL-12 Microcirculation can be a Wonderful Mirror for Blood Substitutes Performance